Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

115375-60-5Abiraterone Related Compound 4

● Under Development

Katalog-Nr.::	VL830010
CAS-Nr.::	115375-60-5
Summenformel::	C22H29F3O5S
Molare Masse::	462.53 g/mol

Wie können wir helfen?

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 115375-60-5

Parent drug

Abiraterone

IUPAC-Name

(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-(((trifluoromethyl)sulfonyl)oxy)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Pharmakopöe-Synonyme

N/A

Other Synonyms

Prasterone Acetate Triflate; [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; [10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; (3beta)-Androsta-5,16-diene-3,17-diol 3-Acetate 17-(Trifluoromethanesulfonate); 3beta-Acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulfonate; Androsta-5,16-diene-3beta,17-diol 3-Acetate 17-Trifluoromethanesulfonate; (3)-Androsta-5,16-diene-3,17-diol 3-Acetate 17-(Trifluoromethanesulfonate); 3, A-Acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulfonate

SMILES

CC(O[C@H]1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)C(OS(=O)(C(F)(F)F)=O)=CC[C@@]4([H])[C@]3([H])CC=C2C1)=O

InChI

InChI=1S/C22H29F3O5S/c1-13(26)29-15-8-10-20(2)14(12-15)4-5-16-17-6-7-19(21(17,3)11-9-18(16)20)30-31(27,28)22(23,24)25/h4,7,15-18H,5-6,8-12H2,1-3H3/t15-,16-,17-,18-,20-,21-/m0/s1

Beschreibung

Abiraterone Related Compound 4 is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Abiraterone. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications.